PPP2R2B RNAi Summary
| Specificity |
protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), beta isoform (PPP2R2B), transcript variant 5, mRNA
|
| Gene |
PPP2R2B
|
Applications/Dilutions
| Application Notes |
This RNAi causes protein knockdown.
|
Packaging, Storage & Formulations
| Storage |
Store at -20C. Avoid freeze-thaw cycles.
|
Notes
This product is produced by and distributed for Abnova, a company based in Taiwan.
Alternate Names for PPP2R2B RNAi
- B55BETA
- FLJ95686
- MGC24888
- PP2A subunit B isoform B55-beta
- PP2A subunit B isoform beta
- PP2A subunit B isoform PR55-beta
- PP2A subunit B isoform R2-beta
- PP2A, subunit B, B-beta isoform
- PP2AB55BETA
- PP2ABBETA
- PP2APR55B
- PP2APR55BETA
- PR2AB55BETA
- PR2ABBETA
- PR2APR55BETA
- PR52B
- PR55BETA
- PR55-BETA
- protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), beta isoform
- protein phosphatase 2 (formerly 2A), regulatory subunit B, beta isoform
- protein phosphatase 2, regulatory subunit B, beta
- SCA12
- serine/threonine protein phosphatase 2A, 55 kDa regulatory subunit B, betaisoform
- serine/threonine protein phosphatase 2A, neuronal isoform
- serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B betaisoform
- spinocerebellar ataxia 12
Background
Chimera RNA interference (chimera RNAi) is process by which small interfering RNA/DNA chimera triggers the destruction of mRNA for the original gene. The discovery work, design, and application of chimera RNAi has been pioneered by Professor Kaoru Saigo and Dr. Kumiko Ui-Tei at the University of Tokyo. Chimera RNAi has many advantages over the conventional siRNAs. First, it has been demonstrated to have reliable knock-down for over 10,000 human genes. Because the human genome is composed of an intricate, genetic network, chimera RNAis unique design has successfully obviated the off-target effects including microRNA-based influence. Another advantage of the chimera RNAi technology is its effectiveness at low concentrations (0.5nM to 5nM); only mRNA is destroyed so genomic genes are not affected. Finally, having both the sense and anti-sense strands consisting RNA/DNA chimera, it offers much greater compound stability for streamlining in vitro and in vivo assays and applications while minimizing interferon induction and other adverse reactions.
